PLYX Latest Press Releases

-- April 1, 2026 --

Polaryx Therapeutics To Participate In The 25th Annual Needham Virtual Healthcare Conference Globe Newswire 8:30 AM

-- March 17, 2026 --

Polaryx Therapeutics Receives FDA Fast Track Designation for PLX-200 for Late-Infantile Neuronal Ceroid Lipofuscinosis (CLN2 Disease) Globe Newswire 8:30 AM

-- March 12, 2026 --

Polaryx Therapeutics Deepens Engagement with the Krabbe Disease Community Through Scientific and Patient Advocacy Events Globe Newswire 8:30 AM

-- February 27, 2026 --

Polaryx Therapeutics Marks Rare Disease Day, Reaffirming Commitment to Patients with Rare Pediatric Lysosomal Storage Disorders Globe Newswire 8:30 AM

-- February 17, 2026 --

Polaryx Therapeutics Selects Contract Research Organization for SOTERIA Phase 2 Basket Trial Globe Newswire 8:30 AM

-- February 10, 2026 --

Polaryx Announces Key Pre-Clinical Data Related to SOTERIA at the 22nd Annual WORLDSymposium Globe Newswire 8:30 AM

-- February 5, 2026 --

Polaryx Therapeutics Welcomes New Members of the Board of Directors Globe Newswire 8:30 AM

-- February 3, 2026 --

Polaryx to Present Late-Breaker Data Related to SOTERIA at the 22nd Annual WORLDSymposium as Company Prepares for SOTERIA Trial Launch Globe Newswire 8:30 AM

-- February 2, 2026 --

Polaryx Therapeutics Announces Direct Listing on Nasdaq; Shares to Begin Trading Under the Symbol "PLYX" Globe Newswire 8:30 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software